These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14500601)

  • 1. YKL-40 as a marker of joint involvement in inflammatory bowel disease.
    Bernardi D; Podswiadek M; Zaninotto M; Punzi L; Plebani M
    Clin Chem; 2003 Oct; 49(10):1685-8. PubMed ID: 14500601
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum human cartilage glycoprotein 39 as a marker of arthritis associated with inflammatory bowel disease.
    Punzi L; Podswiadek M; D'Incà R; Zaninotto M; Bernardi D; Plebani M; Sturniolo GC
    Ann Rheum Dis; 2003 Dec; 62(12):1224-6. PubMed ID: 14644865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
    Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis.
    Harvey S; Whaley J; Eberhardt K
    Scand J Rheumatol; 2000; 29(6):391-3. PubMed ID: 11132209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum levels of YKL-40 in patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Dimoulios P; Vardas E; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
    Int J Colorectal Dis; 2003 May; 18(3):254-9. PubMed ID: 12673492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Observations on the increased serum levels of YKL-40 in patients with rheumatoid arthritis and osteoarthritis].
    Morgante M; Metelli MR; Morgante D
    Minerva Med; 2001 Jun; 92(3):151-3. PubMed ID: 11404723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease.
    Vind I; Johansen JS; Price PA; Munkholm P
    Scand J Gastroenterol; 2003 Jun; 38(6):599-605. PubMed ID: 12825867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome.
    Knudsen LS; Klarlund M; Skjødt H; Jensen T; Ostergaard M; Jensen KE; Hansen MS; Hetland ML; Nielsen HJ; Johansen JS
    J Rheumatol; 2008 Jul; 35(7):1277-87. PubMed ID: 18597410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease.
    La Montagna G; D'Angelo S; Valentini G
    J Rheumatol; 2003 Oct; 30(10):2147-51. PubMed ID: 14528508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity.
    Johansen JS; Stoltenberg M; Hansen M; Florescu A; Hørslev-Petersen K; Lorenzen I; Price PA
    Rheumatology (Oxford); 1999 Jul; 38(7):618-26. PubMed ID: 10461474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.
    Conrozier T; Carlier MC; Mathieu P; Colson F; Debard AL; Richard S; Favret H; Bienvenu J; Vignon E
    Ann Rheum Dis; 2000 Oct; 59(10):828-31. PubMed ID: 11005786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction.
    Johansen JS; Kirwan JR; Price PA; Sharif M
    Scand J Rheumatol; 2001; 30(5):297-304. PubMed ID: 11727845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YKL-40 is a serum biomarker reflecting the severity of cutaneous lesions in psoriatic arthritis.
    Imai Y; Aochi S; Iwatsuki K; Sano H; Yamanishi K
    J Dermatol; 2013 Apr; 40(4):294-6. PubMed ID: 23397985
    [No Abstract]   [Full Text] [Related]  

  • 14. Is glycoprotein YKL40 a new marker for joint disorders?
    Vignon E
    Joint Bone Spine; 2001 Dec; 68(6):454-6. PubMed ID: 11808979
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters.
    Matsumoto T; Tsurumoto T
    Clin Exp Rheumatol; 2001; 19(6):655-60. PubMed ID: 11791636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings.
    Ahmed SF; Attia EA; Saad AA; Sharara M; Fawzy H; El Nahrery EM
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):682-8. PubMed ID: 25087779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity.
    Peltomaa R; Paimela L; Harvey S; Helve T; Leirisalo-Repo M
    Rheumatol Int; 2001 Jul; 20(5):192-6. PubMed ID: 11518039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions.
    Vos K; Steenbakkers P; Miltenburg AM; Bos E; van Den Heuvel MW; van Hogezand RA; de Vries RR; Breedveld FC; Boots AM
    Ann Rheum Dis; 2000 Jul; 59(7):544-8. PubMed ID: 10873965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [YKL 40: marker of disease activity in rheumatoid arthritis?].
    Morgante M; Di Munno O; Morgante D
    Minerva Med; 1999; 90(11-12):437-41. PubMed ID: 10829806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate.
    Knudsen LS; Ostergaard M; Baslund B; Narvestad E; Petersen J; Nielsen HJ; Ejbjerg BJ; Szkudlarek M; Johansen JS
    Scand J Rheumatol; 2006; 35(6):489-91. PubMed ID: 17343261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.